During pregnancy there is a dramatic reduction in the serum levels of
agalactosyl IgG (GOIgG) in both normal women and those with rheumatoid
arthritis. ln order to determine if a similar reduction in GOIgG were
apparent in fetal serum, a comparison of the galactose content of IgG
from nine paired samples of umbilical vein or fetal blood and periphe
ral maternal serum, at gestational ages ranging from 16-41 weeks was p
erformed. The full-term maternal IgG samples were highly galactosylate
d, so confirming previous observations of reduced GOIgG levels during
Pregnancy. In addition every palled sample of fetal Ige had a higher l
evel of galactosylation than the corresponding maternal IgG. Therefore
, during pregnancy there is both a reduced biosynthesis of the GOIgG g
lycoform by the mother, and a restriction of its transport across the
placenta. The ratio of estimated GOIgG in fetal and maternal serum was
found to be related to changes in IgG transport, and in particular th
e active transport of IgG(1) across the placenta during gestation. Our
data suggest that the placental Ige transport mechanism is either car
bohydrate independent by discriminating for IgG(1), or is carbohydrate
dependent selecting for highly galactosylated IgG glycoforms. This st
udy emphasizes the weed for further investigations on the biological f
unction of GOIgG in normal physiological states, in addition to diseas
e states, such as juvenile and adult rheumatoid arthritis, where eleva
ted GOIgG levels correlate with disease activity.